LivaNova PLC (LIVN)

62.41 -0.71 (-1.12%) At close: 04:00PM EDT

LivaNova PLC

20 Eastbourne Terrace
London W2 6LG
United Kingdom
44 20 3325 0660
https://www.livanova.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 2,900

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Alex Shvartsburg	Chief Financial Officer	1.2M	N/A	1971
Mr. Michael D. Hutchinson	Senior VP, Chief Legal Officer & Company Secretary	1.09M	N/A	1971
Ms. Trui Hebbelinck	Chief Human Resources Officer	895.05k	N/A	1973
Mr. Vladimir A. Makatsaria	CEO & Director	N/A	N/A	1973
Mr. Badri Amurthur	Chief Technology Officer	N/A	N/A	N/A
Lindsey Little	Senior Director of Investor Relations	N/A	N/A	N/A
Deanna Wilke	Vice President of Corporate Communications	N/A	N/A	N/A
Mr. Matthew Joseph Dodds III	Senior Vice President of Corporate Development & IT	N/A	N/A	N/A
Dr. Bryan D. Olin Ph.D.	Senior VP & Head of Product Development - Neuromodulation	N/A	N/A	1967
Mr. Ryan Miller	President of Advanced Circulatory Support	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Corporate governance

LivaNova PLC’s ISS governance QualityScore as of 1 May 2024 is 2. The pillar scores are Audit: 6; Board: 1; Shareholder rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.